Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
The Journal of Clinical Investigation|August 1, 1983
Genetic regulation of a structural polymorphism of human C3b receptorW W Wong, J G Wilson, D T FearonJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1976
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertaseM R Daha, D T Fearon, K F AustenThe Journal of Allergy and Clinical Immunology|September 1, 1981
Clinical and biochemical effects of stanozolol therapy for hereditary angioedemaA L Sheffer, D T Fearon, K F AustenProceedings of the National Academy of Sciences of the United States of America|August 1, 1978
Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytesJ K Czop, D T Fearon, K F AustenThe Journal of Allergy and Clinical Immunology|December 1, 1987
Hereditary angioedema: a decade of management with stanozololA L Sheffer, D T Fearon, K F AustenJournal of Virology|August 1, 1994
Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cellsD R Martin, R L Marlowe, J M AhearnImmunopharmacology|July 17, 1999
Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune toleranceJ S Navratil, L C Korb, J M AhearnThe Journal of Experimental Medicine|November 14, 1997
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytesC C Delibrias, J E Floettmann, M Rowe, et al.The New England Journal of Medicine|May 1, 1975
Activation of the properdin pathway of complement in patients with gram-negative bacteremiaD T Fearon, S Ruddy, P H Schur, et al.The Journal of Experimental Medicine|December 20, 2000
Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6R Reljic, S D Wagner, L J Peakman, et al.Pageof 16